Here is Matt Lowdon‘s weekly deals update, covering news across Medical Technology and Life Sciences. News includes CAR-T, AI Scientists, urology, and more.
➡️ NeuroVision Imaging, Inc., which is working toward regulatory approval for its early Alzheimer’s detection technology, has acquired fellow diagnostics maker Durin Life Sciences Inc. for an undisclosed price.
➡️ As the wave of in vivo CAR-T hype crests, CREATE Medicines is catching the swell with a $122 million series B meant to back its early pipeline of autoimmune and cancer candidates.
➡️ Fosun Pharma has paid $60 million for an option on AriBio’s late-phase Alzheimer’s disease program, securing the chance to expand its rights to the asset in exchange for a further $80 million.
➡️ AstraZeneca is the latest Big Pharma company looking to tap into agentic artificial intelligence, inking a three-year licensing deal with OWKIN to leverage its autonomous “AI Scientist” platform.
➡️ Alphabet’s AI biotech Isomorphic Labs bags $2.1B series B to fuel next-gen drug design model
➡️ FUJIFILM Healthcare Americas Corporation has signed a deal with Ardent Health to bring its enterprise imaging software to hospitals and clinics in six states.
➡️ Cambridge-based Tolemy Bio has raised €1.4m in pre-seed financing to develop Orbit, an AI-native platform designed to help biopharma teams interpret, optimise and control cell-based therapeutic processes.
➡️ INFEX Therapeutics has raised £4.3 million to advance an anti-infective pipeline led by a midphase drug candidate.
➡️ UroMems, a worldwide leader in medical technology and mechatronic solutions for urology, has secured $60 million in a strategic round of funding
➡️ Drummond Scientific Company, a leading manufacturer of medical technology, diagnostic, and sample collection devices, has announced the acquisition of Accu-Glass LLC, a Drummond Scientific Company,
===============
Newton Colmore is a specialist search firm and we connect exceptional engineering and scientific talent with impactful companies, globally.